(1R, 4S, 8R, 9R, 12S, 13S, 14R, 16S, 17R, 19R)-17-[(Ethylsulfanyl)methyl]-9,14-dihydroxy-7,7-dimethyl-2,18-dioxo-3,10-dioxapentacyclo[14.2.1.01,13.04,12.08,12]nonadecan-19-yl acetate acetone solvate

被引：1
|
作者：
Shi, Hao [1 ]
Sun, Hong Xiang [2 ]
机构：
[1] Zhejiang Univ Technol, Coll Pharmaceut Sci, Hangzhou 310014, Zhejiang, Peoples R China
[2] Zhejiang Univ, Coll Anim Sci, Hangzhou 310029, Zhejiang, Peoples R China
来源：
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE | 2009年 / 65卷
关键词：
D O I：
10.1107/S1600536808043341
中图分类号：
O7 [晶体学];
学科分类号：
0702 ; 070205 ; 0703 ; 080501 ;
摘要：
The title compound, C24H32O8S center dot C3H6O, features three six-membered and two five-membered rings. The six-membered rings adopt chair, boat and slightly distorted boat conformations whereas one five-membered ring adopts an approximate envelope conformation and the other a twist conformation. Disorder was modelled for the ethylthio group with the ethyl-C atoms resolved over three positions with occupancies of 0.58 (4), 0.23 (4) and 0.19 (3). In the crystal, an O-H center dot center dot center dot O hydrogen bond links the molecules into chains.
引用
收藏
页码：O202 / U3042
页数：14
相关论文
共 12 条
  • [1] 1R,4S,8R,9S,12S,13S,14R,16S,19R)-19-Acetoxy-14-hydroxy-7,7-dimethyl-17-methylene-2,18-dioxo-3,10-dioxapentacyclo[14.2.1.01,13.04,12.08,12]nonadec-9-yl acetate
    Shi, Hao
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2007, 63 : O4800 - U5908
  • [2] (1R,4S,8R,12S,13S,14R,16S,17R,19R)-14-hydroxy-7,7,17-trimethyl-2,9,18-trioxo-3,10-dioxapentacyclo[14.2.1.01,13.04,12.08,12]nonadec-19-yl acetate
    Shi, Hao
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2007, 63 : O4495 - U5082
  • [3] 1R,4S,8R,12S,13S,14R,16S,19R)-14-hydroxy-7,7-dimethyl-17-methylene-2,9,18-trioxo-3,10-dioxapentacyclo[14.2.1.01,13.04,12.08,12]nonadec-19-ylacetate
    Shi, Hao
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2007, 63 : O4439 - U4561
  • [4] (8S,9R,10S,11S,13S,14S,16S,17R)-4,4-Dichloro-16β-methyl-3,20-dioxo-17,21-bis(propanoyloxy)-5β,8β-epoxypregna-1,9-diene
    Ketuly, Kamal Aziz
    Hadi, A. Hamid A.
    Ng, Seik Weng
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2009, 65 : O2220 - U2621
  • [5] Crystal structure of (5R,8R,9R,10R,12R,13R,14R, 17S,17Z)-2-((3-fluoropyridin-4-yl)methylene)-12-hydroxy-4,4,8,10,14-pentamethyl-17-((R)-2,6,6-trimethyltetrahydro-2H-pyran-2-yl)hexadecahydro-3H-cyclopenta[a]phenanthren-3-one, C36H52FNO3
    Liu, Zi-Yu
    Wang, Wen-Shui
    Jiang, Sheng
    Zhao, Feng-Lan
    Meng, Qing-Guo
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2023, 238 (06): : 1237 - 1239
  • [6] Crystal structure of (S)-2-[(3S,8S,9S,10R,13S,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-N-methoxy-N-methylpropanamide (Fernholz Weinreb amide)
    Viktorsson, Elvar Orn
    Astrand, Ove Alexander Hogmoen
    Haseeb, Rasha Sabah
    Goerbitz, Carl Henrik
    Rongved, Pal
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2015, 71 : 275 - +
  • [7] Crystal structure of (5R,8R,9R,10R,12R, 13R,14R,17S)-2-(E-3-fluorobenzylidene)-12-hydroxy-4,4,8,10,14-pentamethyl-17-((R)-2,6,6-trimethyltetrahydro-2H-pyran-2-yl) hexadecahydro-3H-cyclopenta[a]phenanthren-3-one, C37H53FO3
    Cheng, Kuo
    Song, Ya-Bin
    Meng, Qing-Guo
    Wang, Bao-Gang
    Hou, Yun
    Wang, Wen-Shui
    Jiang, Sheng
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2024, 239 (02): : 179 - 182
  • [8] Time-Dependent Inhibitory Effects of (1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-Dihydroxy-12-(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylvinyl-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(2-oxopropyl)-11,28-dioxa-4-azatricyclo[22.3.1.04.9]octacos-18-ene2,3,10,16-tetrone(FK1706), a Novel Nonimmunosuppressive Immunophilin Ligand, on CYP3A4/5 Activity in Humans in Vivo and in Vitro
    Minematsu, Tsuyoshi
    Lee, Jennifer
    Zha, Jiuhong
    Moy, Selina
    Kowalski, Donna
    Hori, Katsuyuki
    Ishibashi, Koji
    Usui, Takashi
    Kamimura, Hidetaka
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (02) : 249 - 259
  • [9] The crystal structure of (3S,8R,10R,14R)-17-((2S,5S)-5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl)-4,4,8,10,14-pentamethyl-12-oxohexadecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate, C32H52O5
    Liu, Li
    Wang, Hui-yun
    Zhou, Xia
    Zhang, Sheng-Nan
    Chen, Xiao-Qian
    Zhao, Feng-Lan
    Meng, Qing-Guo
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2020, 235 (06): : 1547 - 1549
  • [10] Crystal structure of (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-17-((4-(2-phenylpropyl)phenyl)ethynyl)-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one, C36H42O2
    Li, Xinling
    Deng, Weijie
    Huang, Yubing
    Hu, Jinhui
    Li, Yibiao
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2024, 239 (03): : 411 - 413
12